Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6 Colorectal Neoplasms 5 Neoplasms 4 Malnutrition 3 Lung Neoplasms 3 Diarrhea 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Mucositis 2 Inflammation 2 Enteritis 2 Chalazion 2 Carcinoma, Hepatocellular 2 Thyroid Neoplasms 1 Squamous Intraepithelial Lesions 1 Smoldering Multiple Myeloma 1 Radiation Injuries 1 Psychological Well-Being 1 Psoriasis Vulgaris 1 Polycystic Ovary Syndrome 1 Periampullary Carcinoma Nos 1 Pelvic Neoplasms 1 Pelvic Inflammatory Disease 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Neoplasms, Second Primary 1 Muscle Invasive Bladder Cancer (MIBC) 1 Multiple Myeloma 1 Motor Activity 1 Monoclonal Gammopathy of Undetermined Significance 1

Interventions

Fluorouracil 26 Radiotherapy 17 Mitomycin 17 Cisplatin 12 Capecitabine 12 pembrolizumab 10 Cyclophosphamide 9 Radiation 8 Paclitaxel 8 fludarabine 7 Specimen Handling 7 Nivolumab 7 Carboplatin 7 Magnetic Resonance Spectroscopy 6 Cetuximab 6 Biopsy 6 Papillomavirus Vaccines 5 Drug Therapy 5 dehydroftorafur 4 aldesleukin 4 Vaccines 4 Radiotherapy, Intensity-Modulated 4 Irinotecan 4 Watchful Waiting 3 Taxes 3 Oxaliplatin 3 Observation 3 Light Coagulation 3 Ipilimumab 3 Interleukin-2 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Anus Neoplasms × Probiotics × Clear all

NCT03870607 2023-01-17

BISQUIT

AC Camargo Cancer Center

Phase 2 Unknown

Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡